Concepedia

Publication | Open Access

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

DOIFull Paper Access

143

Citations

37

References

2010

Year

Nina Wagener, Stephan Macher‐Goeppinger, Maria Pritsch, Johannes Hüsing, Karin Hoppe‐Seyler, Peter Schirmacher, Jesco Pfitzenmaier, Axel Haferkamp, Felix Hoppe‐Seyler, Markus Hohenfellner
BMC Cancer

Abstract

This study defines EZH2 as a powerful independent unfavourable prognostic marker of CSS in patients with metastatic and non-metastatic RCC.

References

YearCitations

Page 1